Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USShruti Gupta, Jean-Sébastien Rachoin, Amanda K. Leonberg‐Yoo et al.|JAMA Internal Medicine|2020Cited by 1k
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19Shruti Gupta, Sushrut S. Waikar, Wei Wang et al.|JAMA Internal Medicine|2020Cited by 555
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesJennifer E. Flythe, Samantha K. Brenner, Magdalene M. Assimon et al.|American Journal of Kidney Diseases|2020Cited by 234
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19Hanny Al‐Samkari, Shruti Gupta, Wei Wang et al.|Annals of Internal Medicine|2021Cited by 140
Utility of polygenic embryo screening for disease depends on the selection strategyTodd Lencz, Shai Carmi, Daniel Backenroth et al.|eLife|2021Cited by 74